StromaForte MSC solution for infusion clinical trials

Single center, decentralized, parallel group, open, non-randomized, long-term safety follow-up, and exploratory study of long-term effects on inflammatory, immunological, and aging related biomarkers in study participants treated with MSCs.

This study looks at the long-term safety of a treatment called StromaForte MSCs. It checks for any side effects and how it affects things like inflammation and ageing over time in adults. It's an important step in understanding this new treatment.